Comparison
3 Phosphoglycerate Dehydrogenase Deficiency C0580190 vs 3 4 Metacarpal Synostosis C5558402
Clinical comparison between 3 Phosphoglycerate Dehydrogenase Deficiency and 3 4 Metacarpal Synostosis for differential diagnosis and treatment planning.
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
A rare metabolic disorder impairing the body's ability to produce serine, an essential amino acid. It primarily affects the nervous system, causing developmental delay, seizures, and movement difficulties. Management includes serine supplementation and anticonvulsants as needed.
3 4 Metacarpal Synostosis C5558402
Two hand bones (metacarpals) are fused together from birth. May reduce grip strength and affect hand appearance. Management is personalized based on severity.
6 comparison axes
Onset
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
0-5
3 4 Metacarpal Synostosis C5558402
0-0
Onset patterns differ
Severity
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
severe
3 4 Metacarpal Synostosis C5558402
mild
Different severity levels
Chronic
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
Chronic
3 4 Metacarpal Synostosis C5558402
Chronic
Differing course
Communicable
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
No
3 4 Metacarpal Synostosis C5558402
No
Different transmission
Body System
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
metabolic
3 4 Metacarpal Synostosis C5558402
musculoskeletal
Same/different system
Category
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
metabolic
3 4 Metacarpal Synostosis C5558402
other
Different category
Bottom line
3-phosphoglycerate-dehydrogenase-deficiency-C0580190 and 3-4-metacarpal-synostosis-C5558402 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 | 3 4 Metacarpal Synostosis C5558402 | Discriminating power |
|---|---|---|---|
| Neurologic development | May include developmental delay, seizures, and movement difficulty | No neurologic disease is established by the hand finding alone | High |
| Hand structure and function | Metacarpal fusion is not a described feature | Congenital fusion may alter appearance and grip strength | High |
| Systemic metabolic illness | Impaired serine production can affect the nervous system | Primarily a localized musculoskeletal anomaly | High |
When to favor each condition
Choose 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 when
Child with seizures and developmental delay
These features fit the described neurologic disorder, but confirmation needs specialist testing
Moderate
Suspected serine-biosynthesis disorder
Amino-acid and genetic evaluation may be considered; an abnormal result is not itself a diagnosis
Moderate
Need for metabolic and seizure care
Reported management may include serine supplementation and anticonvulsants when indicated
Moderate
Choose 3 4 Metacarpal Synostosis C5558402 when
Congenital third-fourth metacarpal fusion
This localized skeletal finding matches the described condition
High
Grip or appearance concern without neurologic disease
Function and appearance guide personalized musculoskeletal care
Moderate
Hand imaging shows bony union
Imaging supports the structural finding, with clinical correlation still required
High
How key tests differ
| Test | 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 | 3 4 Metacarpal Synostosis C5558402 | Interpretation |
|---|---|---|---|
| Plasma or CSF amino acids | Low serine may be reported; no cutoff is supplied here | No serine abnormality is expected from this condition | Abnormal amino-acid results require clinician and laboratory interpretation |
| Genetic testing | PHGDH-related variants may support diagnosis when correlated clinically | A metabolic gene abnormality is not expected | Genetic results must be interpreted with the phenotype |
| Hand radiograph | No characteristic metacarpal fusion is described | May show congenital third-fourth metacarpal synostosis | Imaging identifies structure, not metabolic disease |
Prognosis comparison
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
- Outcome
- Often severe and chronic, but individual outcome cannot be predicted from these data
- Factors
- Neurologic severity, seizure control, and response to specialist care
3 4 Metacarpal Synostosis C5558402
- Outcome
- Usually mild and chronic, depending on the extent of fusion
- Factors
- Grip limitation, appearance, and need for therapy or surgery
Time frame: Present from birth or early childhood; follow-up may be lifelong
No prevalence, mortality, or treatment-dose data are supplied
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic complications | Seizures, delay, and movement difficulty may occur Not a described feature Neurologic involvement drives clinical urgency on the left |
| Hand function | Not characteristic Grip strength and dexterity may be reduced Functional impact varies and is often described as mild |
| Care burden | Long-term metabolic and seizure care may be needed Observation, therapy, or surgery may be individualized Doses and outcome rates are not established by these data |
Patient education highlights
- HighDistinct conditions
One is a rare metabolic neurologic disorder; the other is congenital hand-bone fusion.
- HighUrgent symptoms
New seizures, developmental regression, or feeding difficulty need prompt assessment.
- MediumHand concerns
Pain, grip, dexterity, and appearance should guide specialist hand care.